Skip to main content

Table 1 Cell cycle distribution of OCUM-2MD3/L-OHP cells.

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Cell Cell cycle Apoptosis rate (%)
  G0/G1 S G2/M  
Control group     
   OCUM-2MD3 47.93 ± 0.35 46.83 ± 2.31 5.22 ± 2.50 1.00 ± 0.11
   OCUM-2MD3/L-OHP 66.03 ± 0.28* 10.4 ± 1.06* 23.25 ± 0.78* 5.21 ± 0.55*
Treatment group     
   OCUM-2MD3 24.80 ± 0.52 49.37 ± 1.59 25.77 ± 1.30Δ 35.53 ± 0.73
   OCUM-2MD3/L-OHP 50.80 ± 2.00 27.80 ± 0.86Δ 21.40 ± 2.79 29.43 ± 0.91*
  1. * Comparisons of different cells in the same group P < 0.05
  2. Δ Comparisons of different cells in different groups P < 0.05